Agilent Technologies is leaving no stone unturned to bolster its Diagnostics and Genomics Group (DGG) segment on the back of its strategic partnerships.
This is evident from its latest distribution agreement with Hamamatsu Photonics K.K., which is well-known for whole slide imaging systems. Per the agreement, Hamamatsu’s NanoZoomer Slide scanner systems, including the S360MD Slide scanner system, will be integrated with Agilent’s digital pathology solutions to create a complete digital pathology workflow. This, in turn, will bolster the development of precision medicine.
Moreover, the combination of solutions from both companies will enable pathology labs to improve patient health outcomes by bolstering diagnostic efficiency and quality with the help of precision medicines.
Hence, the latest move is likely to drive Agilent’s momentum across pathologists.
Read more here.
